Linking Neuroscience and Behavior in COVID-19

Preface

Section A: Introductory chapters and setting the scene

1. The historical aspects of the SARS-CoV-2 virus and the ensuing pandemic

2. Different variants of SARS-CoV-2

3. Lateral flow assay for SARS-CoV-2 infection: Uses and limitations

4. Linking community participation, mobility disabilities, and the COVID-19 pandemic

5. Influence of the sources used to obtain information on COVID-19 and their impact on mental health

Section B: Impact on behavior and psychology

6. The psychological experiences and distress of defined populations in the COVID-19 pandemic: Doctors

7. Impact of COVID-19 on behavior in autism spectrum disorder

8. Prepandemic stressors in mental health responses to the COVID-19 pandemic: Early life adversities and beyond

9. Compulsive hoarding in the COVID-19 pandemic

10. The psychological experiences and distress in Japan and Sweden during the COVID-19 pandemic

11. The COVID-19 pandemic, mental health, and sleep: Linking depression, anxiety, and perceived
stress

12. The Covid-19 pandemic and the occupational overload of health professionals: Indicators of
burnout

13. Neurocognitive sequelae of SARS-CoV-2 infection: Pathogenesis, risk factors, assessment, and implications

14. Acute neurocognitive disorder as a presenting manifestation of COVID-19

15. Mental health and the impact of confinement

16. Cannabis use in the COVID-19 pandemic: Changes in different populations and implications
for policy

17. Impact of COVID-19 on mental health in women: Socioeconomic groups and global aspects

18. Quality of life assessment of patients after COVID-19

19. COVID-19 pandemic and remote working: Toward a new way of working

20. Long COVID and its persistence: A focus on mental health

21. The impact of the COVID-19 pandemic on behavioral and psychological features of vulnerable groups: Patients with multiple sclerosis and their quality of life

Section C: Effects on neurological structures and mechanisms

23. Linking pediatric COVID-19 with basal ganglia and dentate nucleus

24. Sensory disorders, neuroinflammation, and COVID-19

25. The effects of COVID-19 isolations on nonmotor features of Parkinson's disease

26. Myelitis following COVID-19: The road so far

27. The corpus callosum: Effects due to SARS-CoV-2 infection and the mRNA vaccine

28. Assessing the impact of prenatal SARS-CoV-2 exposure on infants' neurodevelopment: A comprehensive analysis of current evidence

29. Electroencephalographic features with COVID-19

30. Survivors of COVID-19 and clinical neuropsychological domain characteristics

31. Neuroinflammation following SARS-CoV-2 infection

32. Functional magnetic resonance imaging and depressive symptoms in subjects with COVID-19

33. Impact of COVID-19 on the brain: Antibodies against brain stem antigens

34. The kynurenine pathway and role in mental health of post-COVID-19 patients

Section D: Management, support and treatments

35. Management of brain tumors in the COVID-19 pandemic

36. The impact of the COVID-19 pandemic on ischemic stroke management: From hyperacute to chronic phase

37. Long COVID and the potential use of palmitoylethanolamide

38. Cognitive assessments in post-COVID syndrome: A focus on the neuropsychological tests and
protocols

39. Supporting individuals with intellectual and developmental disabilities during the COVID-19
pandemic

40. Preserving well-being and quality of life through school-based interventions focused on physical
activity during the COVID-19 pandemic

41. Hesitancy in using COVID 19 prevention behaviors among African Americans: Strategies to
build confidence

42. New strategies for psychological well-being at work

43. Mitigating mental health changes with virtual reality technology during Covid-19: A narrative

44. Music therapy for patients with neurological disorders during COVID-19 pandemic

45. Mental health and the modulating effects of receiving the COVID-19 vaccination

46. Personalized cognitive behavioral therapy on patients with obesity in COVID-19 pandemic

47. Social anxiety disorder and Covid 19: Treatment with cognitive behavioral therapy

48. Burnout during the COVID-19 pandemic: Modulating role of mindfulness

Section E: Case studies with mini review

49. Case study: Evaluation of a long Covid assessment service (LCAS)

50. Case study: Navigating youth mental health and addictions care in the context of the COVID-19 pandemic

51. Case study: Restless leg syndrome associated with COVID-19

Section F: Resources

52. Recommended resources for linking neuroscience and behavior in coronavirus disease
(COVID-19)

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Neurologia e neurofisiologia clínica
• Epidemiologia e estatística médica
• Doenças infecciosas e contagiosas

COVID-19; coronavirus; pandemic; suicide; autism spectrum disorder; stroke; multiple sclerosis; dementia; mental health